CERo Therapeutics, Inc. — Form D
CERo Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-11-27. The offering totals $43.2M, of which $43.2M was reported sold. Industry: Other.
Offering
- Filed: 2019-11-27
- Form: D
- Accession: 0001700501-19-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $43.2M
- Amount sold: $43.2M
- Investors: 31
- Date of first sale: 2019-11-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-354399
Issuer
- Name: CERo Therapeutics, Inc.
- CIK: 0001700501
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 329 OYSTER POINT BLVD., SAN FRANCISCO, CA, 94080
- Phone: 650-491-9600
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Daniel Mark Corey | Director | San Francisco, CA |
| Stan Mark Riddell | Director | San Francisco, CA |
| Stuart Mark Sloan | Director | San Francisco, CA |
| Heather Mark Turner | Director | San Francisco, CA |
| Daniel Mark Corey | Executive Officer | San Francisco, CA |
| Jordan Corey | Executive Officer | San Francisco, CA |
| Lawrence Corey | Executive Officer | San Francisco, CA |
| Daniel Mark Corey | Promoter | San Francisco, CA |
| Jordan Corey | Promoter | San Francisco, CA |
| Lawrence Corey | Promoter | San Francisco, CA |
| Lawrence Corey | Director | San Francisco, CA |
| Jordan Thomas Corey | Executive Officer | San Francisco, CA |
Other filings by this issuer (1)
More